摘要
目的探讨脑蛋白水解物联合血栓通治疗老年脑梗死后遗症的临床疗效。方法选取本院2015年1月至2018年12月接收的老年急性脑梗死后遗症患者248例,由随机双盲法分组,常规组124例仅进行脑蛋白水解物治疗,干预组124例进行脑蛋白水解物联合血栓通治疗,对比两组临床疗效。结果治疗后,干预组患者MH、VT、SF、RE、GH、BP、RP、PF等评分以及治疗有效率均明显高于常规组(P<0.05)。结论脑蛋白水解物联合血栓通治疗老年脑梗死后遗症的临床疗效较好,可及时改善后遗症,能有效提高患者生存质量。
Objective To investigate the clinical efficacy of brain protein hydrolysate combined with Xueshuantong in the treatment of senile cerebral infarction sequelae. Methods A total of 248 elderly patients with acute cerebral infarction sequelae were enrolled in our hospital from January 2015 to December 2018. They were randomly divided into two groups. 124 patients in the conventional group were treated with only brain protein hydrolysate, and 124 patients in the intervention group were brain protein. The hydrolysate was combined with thrombus therapy to compare the clinical efficacy of the two groups. Results After treatment, the scores of MH, VT, SF, RE, GH, BP, RP, PF and treatment were significantly higher in the intervention group than in the conventional group (P<0.05). Conclusion Brain protein hydrolysate combined with Xueshuantong is effective in the treatment of senile cerebral infarction sequelae, which can improve sequelae in time and improve the quality of life of patients.
作者
罗佩仪
LUO Pei-yi(Shiqiao Hospital, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 511400)
出处
《智慧健康》
2019年第20期143-144,共2页
Smart Healthcare
关键词
脑蛋白水解物
血栓通
老年
急性脑梗死
后遗症
Brain protein hydrolysate
Thrombosis
Old age
Acute cerebral infarction
Sequelae
